Select Page

South Delhi Pharma, New Delhi, India

DARZALEX FASPRO ™ (daratumumab and hyaluronidase-fihj) injection

Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call 9891296838 or Email query@southdelhipharma.com to discuss.

DARZALEX FASPRO is a prescription medicine. DARZALEX FASPRO is used to treat multiple myeloma.
INDICATIONS AND USAGE
DARZALEX FASPRO is a combination of daratumumab, a CD38-directed cytolytic antibody, and hyaluronidase, an endoglycosidase, for the treatment of adult patients with multiple myeloma:
• in combination with bortezomib, melphalan and prednisone in newly diagnosed patients who are ineligible for autologous stem cell transplant
• in combination with lenalidomide and dexamethasone in newly diagnosed patients who are ineligible for autologous stem cell transplant and in patients with relapsed or refractory multiple myeloma who have received
at least one prior therapy
• in combination with bortezomib and dexamethasone in patients who have received at least one prior therapy
• as monotherapy, in patients who have received at least three prior lines of therapy including a proteasome inhibitor (PI) and an immunomodulatory agent or who are double-refractory to a PI and an immunomodulatory
agent.
DOSAGE FORMS & STRENGTHS
Injection: 1,800 mg daratumumab and 30,000 units hyaluronidase per 15 mL (120 mg and 2,000 units/mL) solution in a single-dose vial
Manufactured By: Janssen Biotech, Inc
Prescribing Information URL: Click Here

South Delhi Pharma can facilitate the supply of “DARZALEX FASPRO ™ (daratumumab and hyaluronidase-fihj) injection” to all locations in India and other part of countries after fulfilling the legal requirement (if applicable). All Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from South Delhi Pharma.

Category:

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:
info@southdelhipharma.com

4 + 6 =

Daratumumab/hyaluronidase is indicated for the treatment of adults with multiple myeloma:

• in combination with bortezomib, melphalan and prednisone (D-VMP) in newly diagnosed adults who are ineligible for autologous stem cell transplant
• in combination with lenalidomide and dexamethasone (D-Rd) in newly diagnosed adults who are ineligible for autologous stem cell transplant and in people with relapsed or refractory multiple myeloma who have received at least one prior therapy
• in combination with bortezomib and dexamethasone (D-Vd) in adults who have received at least one prior therapy as monotherapy, in adults who have received at least three prior lines of therapy including a proteasome inhibitor (PI) and an immunomodulatory agent or who are double-refractory to a PI and an immunomodulatory agent.
• It was approved for use in the United States in May 2020.

1 review for DARZALEX FASPRO ™ (daratumumab and hyaluronidase-fihj) injection

  1. Facebook Marketing

    I simply couldn’t go away your site before suggesting that I extremely enjoyed the usual information an individual supply for your visitors? Is gonna be back steadily in order to investigate cross-check new posts.

    https://www.blogexpander.com/what-you-should-learn-about-article-syndication/

Add a review

Your email address will not be published.